Vaxart Inc (VXRT)
0.7289
-0.02
(-2.68%)
USD |
NASDAQ |
May 03, 16:00
0.7419
+0.01
(+1.78%)
After-Hours: 20:00
Vaxart Accounts Payable (Quarterly): 1.584M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.584M |
September 30, 2023 | 1.339M |
June 30, 2023 | 4.199M |
March 31, 2023 | 3.882M |
December 31, 2022 | 5.514M |
September 30, 2022 | 7.916M |
June 30, 2022 | 5.007M |
March 31, 2022 | 4.017M |
December 31, 2021 | 3.872M |
September 30, 2021 | 3.745M |
June 30, 2021 | 3.702M |
March 31, 2021 | 4.638M |
December 31, 2020 | 2.133M |
September 30, 2020 | 1.871M |
June 30, 2020 | 1.166M |
March 31, 2020 | 0.793M |
December 31, 2019 | 0.852M |
September 30, 2019 | 1.049M |
June 30, 2019 | 0.61M |
March 31, 2019 | 0.849M |
December 31, 2018 | 0.962M |
September 30, 2018 | 1.301M |
June 30, 2018 | 1.449M |
March 31, 2018 | 1.744M |
December 31, 2017 | 1.70M |
Date | Value |
---|---|
September 30, 2017 | 1.30M |
June 30, 2017 | 1.40M |
March 31, 2017 | 1.80M |
December 31, 2016 | 3.40M |
September 30, 2016 | 1.60M |
June 30, 2016 | 3.90M |
March 31, 2016 | 3.70M |
December 31, 2015 | 1.30M |
September 30, 2015 | 2.90M |
June 30, 2015 | 1.90M |
March 31, 2015 | 1.00M |
December 31, 2014 | 1.70M |
September 30, 2014 | 1.40M |
June 30, 2014 | 2.80M |
March 31, 2014 | 7.30M |
December 31, 2013 | 9.60M |
September 30, 2013 | 2.10M |
June 30, 2013 | 2.40M |
March 31, 2013 | 2.282M |
December 31, 2012 | 4.466M |
September 30, 2012 | 0.333M |
June 30, 2012 | 0.075M |
March 31, 2012 | 0.069M |
December 31, 2011 | 0.146M |
September 30, 2011 | 0.983M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.61M
Minimum
Jun 2019
7.916M
Maximum
Sep 2022
3.047M
Average
3.702M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Novavax Inc | 132.61M |
aTyr Pharma Inc | 3.529M |
Allogene Therapeutics Inc | 5.897M |
AIM ImmunoTech Inc | 6.443M |
Protalix BioTherapeutics Inc | 4.32M |